February 4, 2026 · Form 4 insider transaction
Metzger Michael A bought 440,000 shares of SYNDAX PHARMACEUTICALS INC at $20.43 per share, a transaction worth $8.99M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
1/48th of the shares subject to the option shall vest monthly over a four-year period.